BCRF Announces Tragic Loss of Researcher Dr. Arti Hurria

All the staff of BCRF send their heartfelt condolences to Dr. Hurria’s family and community.

It is with immense sadness that the BCRF community announces the tragic loss of a beloved friend, BCRF researcher, and dedicated physician Dr. Arti Hurria. A BCRF investigator since 2012, Dr. Hurria died from injuries sustained in a car accident in the early morning of November 7 in Los Angeles. All the staff of BCRF send their heartfelt condolences to Dr. Hurria’s family and community.

Many accolades will be written as the news of Dr. Hurria’s death reaches the oncology community and her friends, colleagues, and patients recall personal stories of her influence on their lives and careers. Like them, the BCRF family also recalls her passion for the mission we shared to end breast cancer and improve the lives of those who face a breast cancer diagnosis.

Dr. Hurria touched many of us at BCRF, not the least of which is our Co-Scientific Director, Dr. Larry Norton who mentored Dr. Hurria early in her career at Memorial Sloan Kettering Cancer Center and offered the following tribute:

“There is an ancient Jewish legend based on Proverbs that in every generation there are 36 saintly people on whose virtue the fate of the world depends. Arti was certainly one of these. No one exceeded her kindness, generosity and devotion to family, patients and colleagues and, indeed, all of humanity. Matching this with prodigious medical and scientific skills made her a unique individual. Her vast expansion of geriatric oncology among her other achievements will mark her as a giant—a beloved and saintly giant–for all time.”

The daughter of two doctors, Dr. Hurria always knew medicine would be her calling, too. She found her niche in taking care of older adults with cancer, particularly breast cancer. In a 2018 conversation with BCRF, she shared how she felt personally connected to her patients. “I just feel in my element when I’m taking care of older patients,” she said.

This created an urgency to address the special concerns of older breast cancer patients and the need to incorporate principles of geriatrics into oncology. Dr. Hurria was known by her medical peers as a pioneer of geriatric care, a compassionate and respected colleague, and a mentor. To her patients, she was an unyielding advocate, a friend and confident.

“The breadth and depth of her expertise was unfathomable,” recalled Dr. Hyman Muss, a close friend and BCRF collaborator. “Of all the wonderful, lovely, and selfless people I’ve even worked with or known, Arti was at the top of this list.”

Our thoughts are with Dr. Hurria’s husband, daughter, other family members, patients and colleagues, and the countless others who loved her and admired her. This is a tragic loss for us all.